Enter one or more keywords
 

OFCCP Compliance Review leads to AstraZeneca settlement of $250k involving equal pay

2011-06-10

In 2002, the Office of Federal Contract Compliance Programs conducted a compliance review of AstraZeneca's business center and found that it violated E.O. 11246 by failing to meet its obligations with respect to fair pay.  AstraZeneca will pay $250,000 to 124 women who were subjected to pay discrimination while working at the Philadelphia Business Center in Wayne, PA.  The settlement resolves a lawsuit filed by the Department of Labor against the large pharmaceutical company.  The lawsuit alleged that the company discriminated against female sales specialist by paying them salaries that were, on average, $1,700 less than their male counterparts.

Along with the settlement AstraZeneca entered into a consent decree and agreed to work with OFCCP to conduct a statistical analysis of the base pay of 415 individuals employed full time as "primary care" and "specialty care" level III pharmaceutical sales specialists in 14 states.  If the results of the analysis show that female employees continue to be underpaid, the company will adjust salaries accordingly.

The Company has also agreed to develop and annually update its affirmative action plan and keep all supporting documentation as required by law.